Functional Characterization of RELA Fusion Ependymoma as a Basis for Therapeutic Targeting |
St. Jude Children’s Research Hospital / Stephen Mack, PhD |
'A' Award Grants |
2018 |
Tennessee |
Interrogation of Neuroblastoma Dependencies and RNAs on the Core-Regulatory Circuitry for Therapeutic Inhibition |
St. Jude Children’s Research Hospital / Adam Durbin, PhD |
Young Investigator Grants |
2018 |
Tennessee |
Neurocognitive Outcomes in Survivors of Childhood Leukemia with Down Syndrome |
St. Jude Children’s Research Hospital / Lisa Jacola, PhD |
Psychosocial Grants |
2016 |
Tennessee |
Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment |
Vanderbilt University Medical Center / John Wilson, PhD |
'A' Award Grants |
2015 |
Tennessee |
Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia |
St. Jude Children’s Research Hospital / Charles Mullighan, MD |
Innovation Grants |
2019 |
Tennessee |
The role of PDE4B in Racial Disparities in Outcome of Childhood Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Jun Yang |
Young Investigator Grants |
2010 |
Tennessee |
Testing a Hospital Sleep Hygiene Intervention
|
St. Jude Children’s Research Hospital / Belinda Mandrell, PhD, RN |
Nurse Researcher Grants |
2007 |
Tennessee |
NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Takaya Moriyama, MD/PhD |
Young Investigator Grants |
2018 |
Tennessee |
Platform development for target identification in high risk pediatric leukemias |
St. Jude Children’s Research Hospital / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD |
Crazy 8 Pilots |
2019 |
Tennessee |
Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients |
Vanderbilt University Medical Center / Rachael Schulte, MD |
Young Investigator Grants |
2018 |
Tennessee |